VI region lymph node dissection

Clinical application of carbon nanoparticle lymph node tracer in the VI region lymph node dissection of differentiated thyroid cancer

S. P. Sun, Zhang, Y., Cui, Z. Q., Chen, Q., Zhang, W., Zhou, C. X., Xie, P. P., and Liu, B. G., Clinical application of carbon nanoparticle lymph node tracer in the VI region lymph node dissection of differentiated thyroid cancer, vol. 13, pp. 3432-3437, 2014.

The application and clinical significance of carbon nanoparticle lymph tracer in the VI region (central region) lymph node dissection of differentiated thyroid cancer was investigated. Eighty patients with differentiated thyroid cancer were equally divided into the carbon nanoparticle-marked group (ipsilateral thyroid injection) and the control group (no injection). All patients underwent standard primary tumor treatment and VI lymph node dissection.

Subscribe to VI region lymph node dissection